Analysis of Skeletal Status by Quantitative Ultrasonometry in a Cohort of Postmenopausal Women with High Blood Cholesterol Without Documented Osteoporosis

Ultrasound in Medicine and Biology

Volumn 35, Issue 5, 2009, Pages 717-722

  Nuzzo, Vincenzo ^a   de Milita, Anna Maria ^a   Ferraro, Teresa ^a   Monaco, Antonio ^a   Florio, Enrico ^a   Miano, Pasquale ^a   Montemarano, Emilio ^a   Zuccoli, Alfonso ^a   de Terlizzi, Francesca ^b  

^a San Gennaro Hospital   (Italy)

^b IGEA Biophysics Laboratory   (Italy)

Author keywords

Calcium intake; Hypercholesterolemia; Osteoporosis; Quantitative ultrasonometry

Indexed keywords

BLOOD CHOLESTEROLS; DIETARY TREATMENTS; HYPERCHOLESTEROLEMIA; LIPID PROFILES; OSTEOPOROSIS; PLASMA CHOLESTEROLS; POSTMENOPAUSAL WOMEN; PRIMARY CARES; PROTECTIVE EFFECTS; QUANTITATIVE ULTRASONOMETRY; RISK FACTORS; SERUM CHOLESTEROLS; SPEED OF SOUNDS; STATINS;

BODY FLUIDS; CALCIUM ALLOYS; CHOLESTEROL; ECOLOGY; NUTRITION;

CALCIUM;

CALCIUM; CHOLESTEROL; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;

ADULT; ARTICLE; CALCIUM INTAKE; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DIET THERAPY; FEMALE; HUMAN; HYPERCHOLESTEROLEMIA; MAJOR CLINICAL STUDY; OSTEOPOROSIS; POSTMENOPAUSE; PRIORITY JOURNAL; SKELETON; ULTRASOUND;

AGED; BONE DENSITY; CALCIUM, DIETARY; FEMALE; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; HYPERCHOLESTEROLEMIA; LIFE STYLE; MIDDLE AGED; OSTEOPOROSIS, POSTMENOPAUSAL; POSTMENOPAUSE; RISK FACTORS;

EID: 67349281950     PISSN: 03015629     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ultrasmedbio.2008.11.003     Document Type: Article

References (31)

1. Adami S., Braga V., Zamboni M., Gatti D., Rossigni M., Bakri J., and Battaglia E. Relationship between lipids and bone mass in two cohorts of healthy women and men. Calcified Tissue International 74 (2004) 136-142
2. Bauer D.C. HMG CoA reductase inhibitors and the skeleton: A comprehensive review. Osteoporosis Int 14 (2003) 273-282
3. Chan K.M., Anderson M., and Lau E.M. Exercise intervention: Defusing the world's osteoporosis time bomb. Bull World Health Organ 81 (2003) 827-830
4. Cummings R.S., and Bauer C.D. Do statins prevent both cardiovascular disease and fracture?. JAMA 283 (2000) 3255-3257
5. Cushenberry M.L., and de Bittner R.M. Potential use of Hmg-Coa reductase inhibitors for osteoporosis. Ann Pharmacother 36 (2002) 671-677
6. Carnovale E., and Miuccio F. Tabelle di composizione degli alimenti (1989), Edizioni Istituto Nazionale della Nutrizione, Roma
7. Del Puente A., Postiglione A., Esposito-Del Puente A., Carpinelli A., Romano M., and Oriente P. Peripheral body fat has a protective role on bone mineral density in elderly women. Eur J Clin Nutr 52 (1998) 690-693
8. Edwards C.J., and Spector T.D. Statins as modulators of bone formation. Arthritis Res 4 (2002) 151-153
9. Iqbal M.M. Osteoporosis: Epidemiology, diagnosis and treatment. South Med J 93 (2000) 2-18
10. Kaufmann I.J., and Einhorn T.A. Ultrasound assessment of bone. J Bone Miner Res 8 (1996) 517-525
11. Knopp R.H. Drug treatment of lipid disorders. N Engl J Med 12 (1999) 498-508
12. Lupattelli G., Scarponi A.M., Vaudo G., Siepi D., Roscini A.R., Gemelli F., Pirro M., Latini R.A., Singinzer H., Marchesi S., and Mandarino E. Simvastatin increases bone mineral density in hypercholesterolemic postmenopausal women. Metabolism 53 (2004) 744-748
13. Maggi S., Sorenson A.W., and Steel K. The need of a strict methodology in dietary surveys: The experience of the WHO osteoporosis project. Aging Clin Exp Res 5 (1993) 23-28
14. Mundy G.R. Statin and their potential for osteoporosis. Bone 29 (2001) 495-497
15. Orozco P. Atherogenic lipid profile and elevated lipoprotein (a) are associated with lower bone mineral density in early postmenopausal overweight women. Eur J Epidemiol 19 (2004) 1105-1112
16. Pasco A.J., Kotowicz A.M., Henry M.J., Sanders K.M., and Nicholson C.G. Statin use, bone mineral density, and fracture risk. Arch Intern Med 162 (2002) 537-540
17. Rajamannan N.M., Subramaniam M., Springett M., Sebo C.T., Niekrasz M., Mc Connel J.P., Singh R.J., Stone N.J., Bonow R.O., and Spelberg C.T. Atorvastatin inhibits hypercholesterolemia-induced cellular proliferation and bone matrix production in the rabbit aortic valve. Circulation 105 (2002) 2660-2665
18. Rejenmark L., Buus N.H., Vestergaard P., Andresaen F., Larsen M.L., and Moselkide L. Statins decrease bone turnover in postmenopausal women: a cross-sectional study. Eur J Invest 32 (2002) 581-589
19. Rejenmark L., Buus N.H., Vestergaard P., Heichendorff L., Andreasen F., Larsen L.M., and Mosekilde L. Effects of simvastatin on bone turnover and BMD: A 1-year randomized controlled trial in postmenopausal osteopenic women. J Bone Miner Res 19 (2004) 737-744
20. Rico H., Aguado F., Arribas I., Hernández E.R., Villa L.F., Seco C., and Gervas J.J. Behaviour of phalangeal bone ultrasound in normal women with relation to gonadal status and body mass index. Osteoporos Int 12 (2001) 450-455
21. Rosamond W.D., Chambless L.E., Folsom A.R., Cooper L.S., Conwill D.E., Clegg L., Wang C.H., and Heiss G. Trends in the incidence of myocardial infarction and in mortality due to coronary heart disease, 1987 to 1994. N Engl J Med 339 (1998) 861-867
22. Samelson E.J., Cuppless L.A., Hannan M.T., Wilson P.W.F., Setareh A.W., Vaccarino V., Zhang Y., and Kiel P.D. Long term effects of serum cholesterol on bone mineral density in women and men: The Framingham Osteoporosis Study. Bone 34 (2004) 557-561
23. Solomon H.D., Finkelstein S.J., Wang S.P., and Avorn J. Statin Lipid-lowering drugs and bone mineral density. Pharmacoepidemiol Drug Safety 14 (2005) 219-226
24. Tankò L.B., Bagger Y.Z., Nielsen S.B., and Christiansen C. Does serum cholesterol contribute to vertebral bone loss in postmenopausal women?. Bone 32 (2003) 8-14
25. Tauchmanova' L., Nuzzo V., Del Puente A., Fonderico F., Esposito-Del Puente A., Padulla S., Rossi A., Bifulco G., Lupoli G., and Lombardi G. Reduced bone mass detected by bone quantitative ultrasonometry and DEXA in pre-and postmenopausal women with endogenous subclinical hyperthyroidism. Maturitas 48 (2004) 299-306
26. Varenna M., Binelli L., Zucchi F., Ghiringhelli D., and Sinigaglia L. Unbalanced diet to lower serum cholesterol level is a risk factor for postmenopausal osteoporosis and distal forearm fracture. Osteoporosis Int 12 (2001) 296-301
27. von der Recke P., Hansen M.A., and Hassager C. The association between low bone mass at the menopause and cardiovascular mortality. Am J Med 106 (1999) 273-278
28. Waldmann A., and Kritharides L. The pleiotropic effects of HMG-Coa reductase inhibitors. Drugs 68 (2003) 139-152
29. Wang P.S., Solomon H.D., Mogun H., and Avorn J. HMG-Coa reductase inhibitors and the risk of hip fractures in elderly patients. JAMA 28 (2000) 3211-3216
30. World Health Organization. Assessment of fracture risk and its application to screening for postmenopausal osteoporosis. WHO Technical Report Series 843 (1994), WHO, Geneve
31. Wuster C., Albanese C., De Aloysio D., Duboeuf F., Gambacciani M., Gonnelli S., Glüer C.C., Hans D., Joly J., Reginster J.Y., De Terlizzi F., Cadossi R., and The Phalangeal Osteosonogrammetry Study Group. Phalangeal osteosonogrammetry study: Age-related changes, diagnostic sensitivity, and discrimination power. J Bone Miner Res 15 (2000) 1603-1613